Comparing Anoro Ellipta vs Symbicort
| Anoro Ellipta (umeclidinium / vilanterol) | Symbicort (budesonide / formoterol) |
|
|---|
| Anoro Ellipta (umeclidinium / vilanterol) | Symbicort (budesonide / formoterol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Anoro Ellipta is a once-daily inhalation that may be used to help maintain airway opening in adults with COPD. It is well-tolerated with few side effects, but it should not be used to treat asthma... View more |
Prescription only
Symbicort is a combination inhaler that contains budesonide (a corticosteroid) and formoterol (a long-acting bronchodilator). Symbicort should only be used in people with moderate-to-severe asthma... View more |
Related suggestions COPD
COPD, Maintenance
Popular comparisons
|
|||||||||||||||
| More about Anoro Ellipta (umeclidinium / vilanterol) | More about Symbicort (budesonide / formoterol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Anoro Ellipta has an average rating of 7.1 out of 10 from a total of 69 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 22% reported a negative effect. |
Symbicort has an average rating of 6.6 out of 10 from a total of 226 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Anoro Ellipta side effects |
View all Symbicort side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Anoro Ellipta prices |
View all Symbicort prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Other budesonide / formoterol brands include: Breyna | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
21.3 hours |
7.9 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 501 drugs are known to interact with Anoro Ellipta:
|
A total of 845 drugs are known to interact with Symbicort:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 18, 2013 |
July 21, 2006 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.